These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1198956)

  • 1. [Immunoglobulins and basic fractions of serum proteins in patients under chronic intermittent hemodialysis program].
    Petrácková E; Petrácek E
    Vnitr Lek; 1975 Nov; 21(11):1109-17. PubMed ID: 1198956
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic alterations associated with chronic hemodialysis.
    Rus HG; Cristea A; Gherman M; Niculescu F; Gavan M
    Med Interne; 1983; 21(4):289-95. PubMed ID: 6658343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune complexes in the serum of recipients of renal transplants and of patients in a chronic intermittent hemodialysis program].
    Hrncír Z; Erben J; Tichý M
    Vnitr Lek; 1979 Feb; 25(2):105-10. PubMed ID: 371118
    [No Abstract]   [Full Text] [Related]  

  • 4. [Total haemolytic complement (C'H 50) in patients on intermittent haemodialysis (author's transl)].
    Schmidt P; Boros M; Eibl M; Deutsch E
    Wien Klin Wochenschr; 1974 Nov; 86(22):687-91. PubMed ID: 4460391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular and humoral immunity in patients with chronic renal insufficiency in periodic hemodialysis].
    Cabarcos A; Errasti P; Asín JL; Serrano M; Uribarrena R; Purroy A
    Rev Med Univ Navarra; 1979 Mar; 23(1):55-8. PubMed ID: 552113
    [No Abstract]   [Full Text] [Related]  

  • 7. [Humoral-tissue immunity in patients with chronic kidney failure in hemodialysis (20 cases)].
    Desnues P; Gilly R; Joly R; Bourdais A; Barboux JP; Olmer M
    Mars Med; 1972; 109(5):321-33. PubMed ID: 5076837
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immune status in patients on chronic hemodialysis].
    Ljaljević J; Zlatković Lj; Veljović R; Tanurdzić S; Latković J
    Glas Srp Akad Nauka Med; 1981; (34):129-36. PubMed ID: 7346345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of middle-sized molecules in the blood of children with chronic renal failure during treatment with short-term hemodialysis].
    Gudim VI; Sigalla P; Ivanova VS; Oldag K
    Vopr Med Khim; 1980; 26(6):742-6. PubMed ID: 7456404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum proteins and intermittent hemodialysis in patients with chronic renal failure].
    Ozanian V; Kiriakov Z
    Khirurgiia (Sofiia); 1974; 27(2):122-5. PubMed ID: 4425142
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cellular and humoral immunity in patients on hemodialysis].
    López Gómez JM; Medina MC; Luño J; Alles A; Jofré R; Resano M; García Vinuesa MS; Valderrábano F
    Rev Clin Esp; 1980 Dec; 159(5):335-9. PubMed ID: 7221097
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The humoral immunologic picture in repeatedly dialyzed patients as compared with those with residual diuresis].
    Ursea N; Cristian R; Penescu M; Patrichi D; Călăraşu P; Luban F
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(6):541-4. PubMed ID: 6143376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monthly changes in serum alpha 2-globulin and immunoglobulin levels in chronic hemodialysis patients--with special reference to the occurrence of cancer and blood transfusion].
    Misao A; Saji S; Hosono Y; Takekoshi T; Tanaka S; Sato Y; Mori N; Yasui S; Kuriyama I
    Gan No Rinsho; 1985 Jul; 31(8):953-8. PubMed ID: 2411969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum transcortin levels in patients with chronic hemodialysis.
    De Moor P; Faict D; Verberckmoes R
    Ann Biol Clin (Paris); 1985; 43(3):267-9. PubMed ID: 3927790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.
    Raskova J; Ghobrial I; Czerwinski DK; Shea SM; Eisinger RP; Raska K
    Arch Intern Med; 1987 Jan; 147(1):89-93. PubMed ID: 3492183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza antibody titers after vaccination of chronic renal failure patients; before and during hemodialysis, or on continuous ambulatory peritoneal dialysis.
    Suga T; Niki H; Niikura M; Matsumoto Y; Nishimura T; Nakajima K; Miyazaki M; Endoh M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1990 May; 15(2-3):245-51. PubMed ID: 2130531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitetanus toxoid antibody titer of chronic hemodialysis patients in Iran.
    Sagheb MM; Sajjadi S; Sajjadi G
    Iran J Immunol; 2008 Mar; 5(1):45-50. PubMed ID: 18319524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological findings in kidney insufficiency with and without hemodialysis. II. K cell activity under chronic hemodialysis conditions].
    Varga A; Stosiek P; Lincke HU
    Z Urol Nephrol; 1980 May; 73(5):367-71. PubMed ID: 7456804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.